Patents by Inventor Jean Denis

Jean Denis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • External user notifications in shared folder backed integrated workspaces
    Patent number: 10042900
    Abstract: Disclosed are systems, methods, and non-transitory computer-readable storage media for shared folder backed integrated workspaces. In some implementations, a content management system can provide a graphical user interface (GUI) that integrates communications and content management into a single user interface. The user interface can include mechanisms that allow a user to provide input to generate a new workspace. The user interface can provide a mechanism to allow a user to view conversations related to the workspace and/or content items associated with the workspace. The user interface can present representations of content items associated with the workspace and allow the user to provide input to generate, view, edit, and share content items associated with the workspace.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: August 7, 2018
    Assignee: DROPBOX, INC.
    Inventors: Sean Beausoleil, Matteus Pan, Jean-Denis Greze, Anthony DeVincenzi
  • Method to determine physical properties of the ground
    Patent number: 10024660
    Abstract: The method can determine physical properties of the ground stepped upon by a user wearing a footwear incorporating an accelerometer, and includes: receiving a raw signal from the accelerometer during at least one step being taken by the user on the ground; identifying, in the received raw signal, at least one characteristic signature; associating the at least one characteristic signature to physical properties of the ground; and generating a signal indicating the physical properties based on said association. The generated signal can further be used to advise a user of a risk of falling based on at least the physical properties of the ground.
    Type: Grant
    Filed: August 26, 2013
    Date of Patent: July 17, 2018
    Assignee: UNIVERSITE DU QUEBEC A CHICOUTIMI
    Inventors: Martin Jean-Denis Otis, Bob-Antoine Jerry Ménélas
  • MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Publication number: 20180185364
    Abstract: The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
    Type: Application
    Filed: August 11, 2017
    Publication date: July 5, 2018
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Mark Thomas Miller, Corey Anderson, Vijayalaksmi Arumugam, Brian Richard Bear, Hayley Marie Binch, Jeremy J. Clemens, Thomas Cleveland, Erica Conroy, Timothy Richard Coon, Bryan A. Frieman, Peter Diederik Jan Grootenhuis, Raymond Stanley Gross, Sara Sabina Hadida-Ruah, Haripada Khatuya, Pramod Virupax Joshi, Paul John Krenitsky, Chun-Chieh Lin, Gulin Erdogan Marelius, Vito Melillo, Jason McCartney, Georgia McGaughey Nicholls, Fabrice Jean Denis Pierre, Alina Silina, Andreas P. Termin, Johnny Uy, Jinglan Zhou
  • Linear guanidine derivatives, methods of preparation and uses thereof
    Patent number: 10004702
    Abstract: The present invention relates to linear guanidine derivatives, methods of preparation, uses and pharmaceutical compositions thereof. The compounds of Formulas 1 or 2 exhibit high antimicrobial activity against Gram positive and Gram negative bacteria.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: June 26, 2018
    Assignee: LEAD DISCOVERY SIENA S.R.L.
    Inventors: Maurizio Botta, Giorgio Maccari, Stefania Sanfilippo, Filomena De Luca, Jean-Denis Docquier, Davide Deodato
  • Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator
    Publication number: 20180162839
    Abstract: Compounds of Formula (I): pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed. Also disclosed are solid state forms of Compound 1 and salts and solvates thereof.
    Type: Application
    Filed: December 8, 2017
    Publication date: June 14, 2018
    Inventors: Alexander Russell Abela, Timothy Alcacio, Corey Anderson, Paul Timothy Angell, Minson Baek, Jeremy J. Clemens, Thomas Cleveland, Lori Ann Ferris, Peter Diederik Jan Grootenhuis, Raymond Stanley Gross, Anton V. Gulevich, Sara Sabina Hadida Ruah, Clara Kuang-Ju Hsia, Robert M. Hughes, Pramod Virupax Joshi, Ping Kang, Ali Keshavarz-Shokri, Haripada Khatuya, Paul John Krenitsky, Jason McCartney, Mark Thomas Miller, Prasuna Paraselli, Fabrice Jean Denis Pierre, Yi Shi, Muna Shrestha, David Andrew Siesel, Kathy Stavropoulos, Andreas P. Termin, Fredrick F. Van Goor, Johnny Uy, Timothy John Young, Jinglan Zhou
  • Creating conversations in shared folder backed integrated workspaces
    Patent number: 9959327
    Abstract: Disclosed are systems, methods, and non-transitory computer-readable storage media for shared folder backed integrated workspaces. In some implementations, a content management system can provide a graphical user interface (GUI) that integrates communications and content management into a single user interface. The user interface can include mechanisms that allow a user to provide input to generate a new workspace. The user interface can provide a mechanism to allow a user to view conversations related to the workspace and/or content items associated with the workspace. The user interface can present representations of content items associated with the workspace and allow the user to provide input to generate, view, edit, and share content items associated with the workspace.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: May 1, 2018
    Assignee: DROPBOX, INC.
    Inventors: Sean Beausoleil, Matteus Pan, Jean-Denis Greze, Anthony DeVincenzi
  • Chemical compounds and use thereof for improving muscular quality
    Patent number: 9938315
    Abstract: Chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, a method of improving muscular quality in sarcopenic mammals and treating and/or preventing sarcopenia using the chemical compounds and, in particular, sarcopenic obesity and the associated complications and/or pathologies thereof, such as loss of strength, muscle mass, performance and of physical and movement capacity. Also, a method of improving muscle quality in obese mammals and treating and/or preventing of obesity and associated complications and/or pathologies, advantageously type 2 diabetes and metabolic syndrome, using the chemical compounds.
    Type: Grant
    Filed: May 20, 2015
    Date of Patent: April 10, 2018
    Assignees: BIOPHYTIS, UNIVERSITÉ PARIS 6 PIERRE ET MARIE CURIE
    Inventors: René Lafont, Waly Dioh, Sophie Raynal, Stanislas Veillet, Franck Lepifre, Jean-Denis Durand
  • Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator
    Publication number: 20180093969
    Abstract: Compounds of Formula I: pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
    Type: Application
    Filed: September 29, 2017
    Publication date: April 5, 2018
    Inventors: Timothy Alcacio, Minson Baek, Peter Grootenhuis, Sara Sabina Hadida Ruah, Robert M. Hughes, Ali Keshavarz-Shokri, Rachel McAuley-Aoki, Jason McCartney, Mark Thomas Miller, Fredrick Van Goor, Beili Zhang, Corey Anderson, Thomas Cleveland, Bryan A. Frieman, Haripada Khatuya, Pramod Virupax Joshi, Paul John Krenitsky, Vito Melillo, Fabrice Jean Denis Pierre, Andreas P. Termin, Johnny Uy, Jinglan Zhou, Alexander Russell Abela, Brett Bradley Busch, Prasuna Paraselli, David Andrew Siesel
  • FLUID PRODUCT DISPENSER
    Publication number: 20170361037
    Abstract: A fluid dispenser comprising a body (1), a fluid reservoir (2), a dispenser member, such as a pump or a valve, mounted on said reservoir (2), and a dose indicator device for indicating the number of doses of fluid that have been dispensed or that remain to be dispensed from said reservoir, the dispenser being characterized in that said dose indicator device includes a first safety system for actuating the dose indicator device once the dispenser has performed a predetermined incomplete actuation stroke, even if the dispenser does not perform the complete actuation stroke.
    Type: Application
    Filed: September 1, 2017
    Publication date: December 21, 2017
    Applicant: APTAR FRANCE SAS
    Inventors: Fabien POULARD, Jean-Denis SAUZADE, Yann ROARD
  • METHOD FOR EGFR DIRECTED COMBINATION TREATMENT OF CANCER
    Publication number: 20170312360
    Abstract: The present invention relates to a method of treating patients suffering from cancers driven by deregulated Human Epidermal Growth Factor Receptor (HER/Human EGFR), wherein an irreversible tyrosine kinase inhibitor (TKI) is administered according to a continuous regimen based on an average daily dose in the range of 10 to 50 mg and the mAB is co-administered according to a dosing regimen ranging from an average weekly iv dose of 50 to 500 mg/m2 repeated thrice, twice or once a week, once in two weeks, once in three weeks or at least monthly to a patient in need of such treatment.
    Type: Application
    Filed: July 20, 2017
    Publication date: November 2, 2017
    Inventors: Louis Jean DENIS, Robert Michael LORENCE, Mehdi SHAHIDI, Flavio SOLCA
  • LINEAR GUANIDINE DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF
    Publication number: 20170304235
    Abstract: The present invention relates to linear guanidine derivatives, methods of preparation, uses and pharmaceutical compositions thereof. The compounds of Formulas 1 or 2 exhibit high antimicrobial activity against Gram positive and Gram negative bacteria.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Applicant: LEAD DISCOVERY SIENA S.R.L.
    Inventors: Maurizio BOTTA, Giorgio MACCARI, Stefania SANFILIPPO, Filomena DE LUCA, Jean-Denis DOCQUIER, Davide DEODATO
  • TWO-PART ASSEMBLY OF A LIGHTING DEVICE BY MIRROR WELDING VIA EXPANDER RIBS
    Publication number: 20170305072
    Abstract: The invention relates to a method for assembling a first and a second part of a lighting device for a vehicle by mirror welding, including a step of supplying the parts wherein each part comprises, in the interface area thereof for contact with the other part, a weld bead intended to come into contact against the weld bead of the other part during the mirror welding, the weld bead of at least one of the parts is provided with a plurality of expander ribs (N) spread out along the weld bead, in such a way as to locally expand the width of the weld bead.
    Type: Application
    Filed: September 25, 2015
    Publication date: October 26, 2017
    Applicant: VALEO VISION
    Inventors: Guillaume ALTERMATT, Jean-Marc COLOMBEL, Stephane PAUGAM, Jocelyn PRECHAIS, Jean-Denis TISSIER
  • Modulators of cystic fibrosis transmembrane conductance regulator
    Patent number: 9782408
    Abstract: The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: October 10, 2017
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Mark Thomas Miller, Corey Anderson, Vijayalaksmi Arumugam, Brian Richard Bear, Hayley Marie Binch, Jeremy J. Clemens, Thomas Cleveland, Erica Conroy, Timothy Richard Coon, Bryan A. Frieman, Peter Diederik Jan Grootenhuis, Raymond Stanley Gross, Sara Sabina Hadida Ruah, Haripada Khatuya, Pramod Virupax Joshi, Paul John Krenitsky, Chun-Chieh Lin, Gulin Erdogan Marelius, Vito Melillo, Jason McCartney, Georgia McGaughey Nicholls, Fabrice Jean Denis Pierre, Alina Silina, Andreas P. Termin, Johnny Uy, Jinglan Zhou
  • SHARED FOLDER BACKED INTEGRATED WORKSPACES
    Publication number: 20170285928
    Abstract: Disclosed are systems, methods, and non-transitory computer-readable storage media for shared folder backed integrated workspaces. In some implementations, a content management system can provide a graphical user interface (GUI) that integrates communications and content management into a single user interface. The user interface can include mechanisms that allow a user to provide input to generate a new workspace. The user interface can provide a mechanism to allow a user to view conversations related to the workspace and/or content items associated with the workspace. The user interface can present representations of content items associated with the workspace and allow the user to provide input to generate, view, edit, and share content items associated with the workspace.
    Type: Application
    Filed: June 15, 2017
    Publication date: October 5, 2017
    Inventors: Sean Beausoleil, Matteus Pan, Jean-Denis Greze, Anthony DeVincenzi, Maxwell Johnson, Jack Dubie, Colin Dunn
  • Fluid product dispenser
    Patent number: 9775958
    Abstract: A fluid dispenser comprising a body (1), a fluid reservoir (2), a dispenser member, such as a pump or a valve, mounted on said reservoir (2), and a dose indicator device for indicating the number of doses of fluid that have been dispensed or that remain to be dispensed from said reservoir, the dispenser being characterized in that said dose indicator device includes a first safety system for actuating the dose indicator device once the dispenser has performed a predetermined incomplete actuation stroke, even if the dispenser does not perform the complete actuation stroke.
    Type: Grant
    Filed: May 12, 2016
    Date of Patent: October 3, 2017
    Assignee: APTAR FRANCE SAS
    Inventors: Fabien Poulard, Jean-Denis Sauzade, Yann Roard
  • CHEMICAL COMPOUNDS AND USE THEREOF FOR IMPROVING MUSCULAR QUALITY
    Publication number: 20170226151
    Abstract: Chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, a method of improving muscular quality in sarcopenic mammals and treating and/or preventing sarcopenia using the chemical compounds and, in particular, sarcopenic obesity and the associated complications and/or pathologies thereof, such as loss of strength, muscle mass, performance and of physical and movement capacity. Also, a method of improving muscle quality in obese mammals and treating and/or preventing of obesity and associated complications and/or pathologies, advantageously type 2 diabetes and metabolic syndrome, using the chemical compounds.
    Type: Application
    Filed: May 20, 2015
    Publication date: August 10, 2017
    Inventors: RENÉ LAFONT, WALY DIOH, SOPHIE RAYNAL, STANISLAS VEILLET, FRANCK LEPIFRE, JEAN-DENIS DURAND
  • Shared folder backed integrated workspaces
    Patent number: 9715534
    Abstract: Disclosed are systems, methods, and non-transitory computer-readable storage media for shared folder backed integrated workspaces. In some implementations, a content management system can provide a graphical user interface (GUI) that integrates communications and content management into a single user interface. The user interface can include mechanisms that allow a user to provide input to generate a new workspace. The user interface can provide a mechanism to allow a user to view conversations related to the workspace and/or content items associated with the workspace. The user interface can present representations of content items associated with the workspace and allow the user to provide input to generate, view, edit, and share content items associated with the workspace.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: July 25, 2017
    Assignee: DROPBOX, INC.
    Inventors: Sean Beausoleil, Matteus Pan, Jean-Denis Greze, Anthony DeVincenzi, Maxwell Johnson, Jack Dubie, Colin Dunn
  • MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    Publication number: 20170196862
    Abstract: The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
    Type: Application
    Filed: October 6, 2015
    Publication date: July 13, 2017
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Mark Thomas Miller, Corey Anderson, Vijayalaksmi Arumugam, Brian Richard Bear, Hayley Marie Binch, Jeremy J. Ciemens, Thomas Cleveland, Erica Conroy, Timothy Richard Coon, Bryan A. Frieman, Peter Diederik Jan Grootenhuis, Raymond Stanley Gross, Sara Sabina Hadida-Ruah, Haripada Khatuya, Pramod Virupax Joshi, Paul John Krenitsky, Chun-Chieh Lin, Gulin Erdogan Marelius, Vito Melillo, Jason McCartney, Georgia McGaughey Nicholls, Fabrice Jean Denis Pierre, Alina Silina, Andreas P. Termin, Johnny Uy, Jinglan Zhou
  • ROLL COMPRISING AN ABRADABLE COATING
    Publication number: 20170158565
    Abstract: A protective and abradable coating composition is suitable for application on rolls and more particularly for application on conveyor rolls. The abradable coating is suitable for use in high temperature applications. Rolls incorporating the coating may be produced and used according to disclosed processes and procedures. Application of the composition to rolls reduces corrosion by aluminium melt, and enables the removal of built-up substances by friction. The life time of the roll is thereby increased.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 8, 2017
    Applicant: VESUVIUS FRANCE, S.A.
    Inventors: Jean-denis Nicolas, Gilbert Rancoule, Christian Berry
  • Adhesive composition including deacetylated chitosan
    Patent number: 9670387
    Abstract: The present invention relates to an adhesive composition comprising at least one deacetylated chitosan, an acid and an additional compound.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: June 6, 2017
    Assignees: UNIVERSITE BLAISE PASCAL—CLERMONT II, INSTITUT NATIONAL DE RECHERCHE EN SCIENCES ET TECHNOLOGIES POUR L'ENVIRONNEMENT ET L'AGRICULTURE
    Inventors: Jean-Denis Mathias, Michel Grediac, Hélène De Baynast, Philippe Michaud, Anil Patel